Escalon Medical Corp. (ESMC)

OTCMKTS · Delayed Price · Currency is USD

0.177074

+0.000874 (0.50%)

At close: Oct 28, 2026

Escalon Medical Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	12.74	12.74	12.05	11.98	12.18	10.7
Revenue Growth	5.73%	5.73%	0.54%	-1.63%	13.80%	2.21%
Gross Profit	5.57	5.57	5.51	5.15	5.48	4.61
Operating Income	0.05	0.05	0.13	-0.1	0.48	-0.47
Net Income	2.01	2.01	0.03	-0.18	0.22	-0.03
Earnings Per Share	0.27	0.27	0.00	-0.02	0.03	-0.00
EPS Growth	7064.02%	7064.02%	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
United States	6.83	6.83	6.74	6.36	7.04	5.72
Foreign	5.91	5.91	5.31	5.62	5.14	4.98
Total	12.74	12.74	12.05	11.98	12.18	10.7

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	3.07	3.07	0.55	0.21	0.89	0.59
Total Debt	0.97	0.97	0.52	0.52	0.89	1.21
Net Cash (Debt)	2.09	2.09	0.02	-0.32	-0	-0.61
Net Cash Growth	9178.93%	9178.93%	-	-	-	-
Net Cash Per Share	0.14	0.14	0.00	-0.04	-0.00	-0.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-0.4	-0.4	0.38	-0.6	0.33	-1.05
Capital Expenditures	-0	-0	-0	-0.04	-0.01	-
Free Cash Flow	-0.41	-0.41	0.38	-0.64	0.32	-1.05
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	43.73%	43.73%	45.75%	42.95%	45.00%	43.04%
Operating Margin	0.36%	0.36%	1.11%	-0.87%	3.93%	-4.39%
Pretax Margin	22.56%	22.56%	0.88%	-1.05%	3.75%	0.17%
Profit Margin	15.80%	15.80%	0.23%	-1.48%	1.82%	-0.31%
FCF Margin	-3.20%	-3.20%	3.13%	-5.37%	2.61%	-9.81%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov '26 Nov 3, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PE Ratio	0.65	0.74	85.45	-	8.37	-
P/FCF Ratio	-	-	6.37	-	5.82	-
PS Ratio	0.10	0.12	0.20	0.09	0.15	0.09